Axa S.A. Albemarle Corp Transaction History

Axa S.A.

$32.3 Billion
Q3 2024

A detailed history of Axa S.A. transactions in Albemarle Corp stock. As of the latest transaction made, Axa S.A. holds 9,477 shares of ALB stock, worth $852,835. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,477

Previous 16,758 43.45%

Holding current value

$852,835

Previous $1.6 Million 43.94%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$72.85 - $100.09 $530,420 - $728,755	-7,281 Reduced 43.45%	9,477 $897,000
Q2 2024 Aug 14, 2024	SELL	$92.77 - $135.46 $11.5 Million - $16.8 Million	-124,384 Reduced 88.13%	16,758 $1.6 Million
Q1 2024 May 15, 2024	SELL	$108.73 - $146.89 $3.66 Million - $4.94 Million	-33,649 Reduced 19.25%	141,142 $18.6 Million
Q4 2023 Jul 16, 2024	BUY	$113.26 - $170.8 $3.81 Million - $5.75 Million	33,649 Added 23.84%	174,791 $25.3 Million
Q4 2023 Feb 14, 2024	SELL	$113.26 - $170.8 $3.14 Million - $4.73 Million	-27,684 Reduced 13.67%	174,791 $25.3 Million
Q3 2023 Nov 14, 2023	BUY	$162.63 - $243.44 $14.2 Million - $21.2 Million	87,055 Added 75.42%	202,475 $34.4 Million
Q2 2023 Aug 14, 2023	BUY	$172.91 - $232.22 $699,248 - $939,097	4,044 Added 3.63%	115,420 $25.7 Million
Q1 2023 May 15, 2023	SELL	$208.49 - $290.15 $9.41 Million - $13.1 Million	-45,124 Reduced 28.83%	111,376 $24.6 Million
Q4 2022 Feb 14, 2023	BUY	$214.02 - $325.38 $19.6 Million - $29.7 Million	91,381 Added 140.33%	156,500 $33.9 Million
Q3 2022 Feb 14, 2023	BUY	$195.82 - $307.05 $8,811 - $13,817	45 Added 0.07%	65,119 $17.2 Million
Q3 2022 Nov 14, 2022	BUY	$195.82 - $307.05 $8,811 - $13,817	45 Added 0.07%	65,119 $17.2 Million
Q2 2022 Feb 14, 2023	BUY	$187.76 - $270.92 $492,306 - $710,352	2,622 Added 4.2%	65,074 $13.6 Million
Q2 2022 Aug 15, 2022	BUY	$187.76 - $270.92 $492,306 - $710,352	2,622 Added 4.2%	65,074 $13.6 Million
Q1 2022 Feb 14, 2023	SELL	$172.09 - $246.0 $458,964 - $656,082	-2,667 Reduced 4.1%	62,452 $13.8 Million
Q1 2022 May 13, 2022	SELL	$172.09 - $246.0 $692,318 - $989,658	-4,023 Reduced 6.05%	62,452 $13.8 Million
Q4 2021 Feb 14, 2022	BUY	$214.16 - $283.8 $461,300 - $611,305	2,154 Added 3.35%	66,475 $15.5 Million
Q3 2021 Nov 15, 2021	BUY	$167.91 - $244.03 $2.97 Million - $4.31 Million	17,669 Added 37.87%	64,321 $14.1 Million
Q2 2021 Aug 13, 2021	BUY	$143.7 - $176.01 $1.17 Million - $1.43 Million	8,120 Added 21.07%	46,652 $7.86 Million
Q1 2021 May 14, 2021	BUY	$140.69 - $185.25 $2.03 Million - $2.67 Million	14,414 Added 59.76%	38,532 $5.63 Million
Q4 2020 Feb 12, 2021	SELL	$86.73 - $149.91 $1.62 Million - $2.79 Million	-18,640 Reduced 43.59%	24,118 $3.56 Million
Q3 2020 Nov 13, 2020	SELL	$75.75 - $100.45 $15 Million - $19.9 Million	-198,069 Reduced 82.25%	42,758 $3.82 Million
Q2 2020 Aug 14, 2020	BUY	$52.7 - $86.74 $8.61 Million - $14.2 Million	163,374 Added 210.93%	240,827 $18.6 Million
Q1 2020 May 15, 2020	SELL	$50.9 - $94.31 $4.15 Million - $7.69 Million	-81,527 Reduced 51.28%	77,453 $4.37 Million
Q4 2019 Feb 18, 2020	SELL	$60.74 - $73.04 $16.6 Million - $20 Million	-273,900 Reduced 63.27%	158,980 $11.6 Million
Q3 2019 Nov 14, 2019	BUY	$59.3 - $75.53 $4.46 Million - $5.68 Million	75,264 Added 21.05%	432,880 $30.1 Million
Q2 2019 Aug 13, 2019	BUY	$63.3 - $86.94 $22.1 Million - $30.3 Million	348,873 Added 3990.31%	357,616 $25.2 Million
Q1 2019 May 14, 2019	BUY	$72.69 - $92.28 $635,528 - $806,804	8,743 New	8,743 $717,000
Q2 2018 Aug 13, 2018	SELL	$88.96 - $104.92 $321,679 - $379,390	-3,616 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$89.56 - $137.45 $89,560 - $137,450	-1,000 Reduced 21.66%	3,616 $335,000
Q4 2017 Feb 13, 2018	BUY	$127.48 - $144.58 $127,480 - $144,580	1,000 Added 27.65%	4,616 $590,000
Q3 2017 Nov 13, 2017	BUY	$109.36 - $136.31 $395,445 - $492,896	3,616	3,616 $493,000

Others Institutions Holding ALB

# of Institutions

927

Shares Held

104M

Call Options Held

8.36M

Put Options Held

14.3M

View Full List

About ALBEMARLE CORP

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $10.5B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

More about ALB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account